In patients found to have elevated Lp(a), should we screen broadly and act now — or defer routine measurement and any Lp(a)-targeted treatment until the 2026 outcomes trials report?

Active since Jul 2022

Heat

Patients affected

Resolution

No fixed date yet

Sources

How this gets settled

Resolving trial — not yet identified

Resolution

No fixed date yet

What settles itResolving-trial readout

The debate

Screen and act nowvsWait for outcomes

Who could settle it

Know an expert who could settle this? Suggest one →

Who could fund or run it

Academia

Funders

Industry

Institutions that could fund, run, or adopt

Who this affects

Affected rangeEstimate

15–25

Get involved

Preview

MLDSSELCMO

Not yet tracked

WatchSteer thisSoon

Sources & verification

30linked & dated sources

VerifiedConfirmed against a primary source (registry API or dual-model citation gate).EstimateA computed estimate (e.g. comparable-based cost or modeled range), not a measured value.Scan-reportedReported by the scan and linked to its source — not yet independently verified.